Marker Therapeutics is trading 6.3% lower at $0.90 on October 26, 2026, with no company-specific announcement or clear catalyst identified for the decline.
- A stock research page showed no headlines for October 26.
- The latest company news located was an October 19 FDA grant announcement, which predates the move and does not establish its cause.
- Major U.S. indexes were higher, so the provided market context does not explain the decline.